ProfDavid Henshall
Professor
Physiology and Medical Physics
- ProfessorPhysiology and Medical Physics
- 01 4028629 (Work)
- RCSI, Physiology & Medical Physics, 123 St Stephens Green, Dublin 2
BIOGRAPHY
Professor David Henshall's undergraduate degree was from the University of Bristol, graduating with First Class Honours in Pharmacology in 1994. Postgraduate training on stroke modelling and neuronal injury was in the Department of Pharmacology and the Fujisawa Institute for Neuroscience at the University of Edinburgh, leading to the award of a PhD in Neuropharmacology in 1997. Post-doctoral training in cell death signaling in epilepsy was under Prof Roger Simon at the Department of Neurology, University of Pittsburgh, USA.
Following NIH funding in 1999, Prof Henshall was appointed Assistant Scientist at the newly established Robert S. Dow Neurobiology Laboratories, a private non-profit research institute in Portland, Oregon, USA. An RO1 award for research on apoptosis signaling in epilepsy established an expanded research team and in 2003, promotion to Associate Scientist. In early 2004, Henshall moved to RCSI as Senior Lecturer in Molecular Physiology & Neuroscience.
Prof Henshall has authored over 285 original articles and book chapters. He is author of the book Fine-Tuning Life: A guide to microRNAs, your genome's master regulators (Cambridge University Press, 2024).
He is the past-Chair of the International League Against Epilepsy's Neurobiology Commission and a Benchmark Steward for the National Institutes of Neurological Disorders and Stroke. He coordinated the European FP7 large-scale collaborative project EpimiRNA (2013 - 2018) and co-organised the international conferences EpiXchange I and II which brought together Europe’s major epilepsy research projects.
In 2017, he became Director of FutureNeuro, the Research Ireland Centre for Translational Brain Science. The Centre, hosted at RCSI, is an industry-academia partnership model working to translate findings for patient benefit and includes world-leading investigators in the areas of clinical neurology and psychiatry, genetics, materials science and digital health based across multiple irish universities including TCD, DCU, UCD, Galway, Maynooth, SETU and UCC.
In 2024, he was elected as a Member of the Royal Irish Academy (MRIA), Ireland’s foremost body of experts in the sciences and humanities.
ACADEMIC POSITIONS
- Post-doctoral FellowDepartment of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA1 Jan 1997 - 1 Jan 1999
- Assistant ScientistRobert S. Dow Neurobiology Laboratories, Legacy Health System Portland, Oregon, USA1 Jan 1999 - 1 Jan 2002
- Associate ScientistRobert S. Dow Neurobiology Laboratories, Legacy Health System Portland, Oregon, USA1 Jan 2003 - 1 Jan 2004
- Senior Lecturer, Molecular Physiology & NeuroscienceDepartment of Physiology and Medical Physics , Royal College of Surgeons in Ireland Dublin, Ireland1 Jan 2004 - 1 Jan 2008
- Associate ProfessorRoyal College of Surgeons in Ireland Dublin, Ireland1 Jan 2009 - 1 Jan 2013
- Professor of Molecular Physiology & NeuroscienceRoyal College of Surgeons in Ireland, Dublin, Ireland1 Jan 2013
- Director, FutureNeuroRoyal College of Surgeons in Ireland, Dublin, Ireland1 Sep 2017 - 31 Aug 2023
DEGREES
- Doctor of Philosophy, Neuropharmacology of ischemic brain injury.Department of Pharmacology, University of Edinburgh, Edinburgh, UK25 Dec 1997
- Bachelor of Science, First Class, PharmacologyDepartment of Pharmacology, University of Bristol, Bristol, UK25 Dec 1994
- Postdoctoral FellowshipDepartment of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania,, United States1997 - 1999
CERTIFICATIONS
- License for scientific procedures on animalsHome Office, London, United Kingdom1994
- Radiation Safety Officer qualificationState of Oregon, Oregan, United States2000
- Animal Handling CertificateLAST Ireland, Ireland2014
POSTGRADUATE TRAINING
- PhD in NeuropharmacologyUniversity of Edinburgh, Pharmacology, Edinburgh, United Kingdom1 Sep 1994 - 1 Sep 1997Predoctoral Fellowship
RESEARCH SUB-AREAS
- Therapeutics
- Epilepsy
SUSTAINABLE DEVELOPMENT GOALS (UNSDGS)
- 3 Good Health and Well Being